The APA Office of Health Care Innovation is pleased to announce that APA is now a partner organization in the Food and Drug Administration’s Network of Experts programopens in new window and subsidiary Network of Digital Health Expertsopens in new window. This partnership creates an exciting opportunity for APA members to provide the FDA with expertise on a wide range of topics, including digital mental health.
As the only behavioral health organization participating in the program, APA brings unique and essential expertise to the initiative. Its member scientists and clinicians will be called upon to supplement existing knowledge within the FDA’s Center for Devices and Radiological Health (CDRH) and the Center for Drug Evaluation and Research (CDER). This collaboration will better enable the FDA to streamline the resolution of issues, complaints, or the evaluation of complex medical devices, and it will ensure behavioral expertise is appropriately considered in those efforts.
To match member psychologists quickly and efficiently with FDA calls for expertise, APA has developed a database of members willing to take advantage of this opportunity. APA is seeking member psychologists with expertise in the following areas:
- artificial intelligence
- wearables
- digital therapeutics
- real-world evidence
- cybersecurity
- psychometrician expertise related to incorporating patient input into regulatory submissions
- computerized behavioral therapy and other digital health therapeutic devices
Expertise is also sought for psychiatric conditions including:
- obsessive compulsive disorder
- generalized anxiety disorder
- insomnia
- major depressive disorder
- substance use disorder
- posttraumatic stress disorder
- autism spectrum disorder
- attention deficit hyperactivity disorder
Participating experts may be tapped for such areas as pre- and postmarket issues, clinical care, and new and evolving developments in digital health.
If you are an APA member and have expertise in any of the areas listed above or in other areas that may be of interest to the FDA’s CDRH and CDER, APA strongly encourages you to sign up to be included in the network:


